Apr 12, 2013 ... The case is Shire LLC v. Neos Therapeutics, Inc., case number 3:13-cv-01452, in
the U.S. District Court for the Northern District of Texas.
Sep 9, 2014 ... DALLAS & FORT WORTH, Texas----Neos Therapeutics, Inc. , a specialty ... Its
Amphetamine Polistirex XR-ODT (NT-0202) With Shire LLC ...
SHIRE LLC v. AMERIGEN PHARMACEUTICALS LIMITED. 1:14-cv-06095; Filed:
10/01/2014; Case Updated Daily; Latest Docket Entry: 08/17/2016; PACER.
Orange Book: Approved Drug Products with Therapeutic Equivalence
Evaluations. Share · Tweet ... Search by Applicant (Company). OR. Select one or
The average difference between treatments (R-AMPH vs. placebo) was
estimated ..... Shionogi Pharma, and Shire Pharmaceuticals; a speaker and
research support ... Neos Therapeutics, and Rhodes Pharmaceuticals; and a
research support for .... Psychopharmacology are provided here courtesy of Mary
Ann Liebert, Inc.
Browse all medications: a b c d e f g h i j k l m n o p q r s t u v w x y z ... Information
includes company addresses, telephone numbers, stock quotes, links to
corporate websites, ... Search the Pharmaceutical Company Database ... Napo
Pharmaceuticals, Inc.Neos Therapeutics, Inc.Neurocrine Biosciences, Inc.
This study was funded by Neos Therapeutics, Inc (Grand Prairie, TX). ... Editorial
support was provided by Liqing Xiao, PhD, of AlphaBioCom, LLC (King of
Prussia, PA). ... Dr. Ann Childress reports consultant relationships with Shire,
Novartis, Pfizer, ..... vs placebo: 75.7 [67.0, 84.4]; p <0.0001) on the classroom
... or Sprinkles Versus Methylphenidate Immediate-Release Tablets (Ritalin<sup>®</sup>) in
..... Enzymotec, GencoSciences LLC, Lupin, Neurovance, Sunovion, and Shire. ...
Eli Lilly, Ironshore, Neos Therapeutics Inc., NextWave Pharmaceuticals, Noven, ...
Feb 12, 2016 ... TTF was significantly longer in GXR versus placebo (p = 0.003). ...... The study
was sponsored by Shire Development, LLC. ... Ironshore, Lupin, Neos,
Neurovance, NFL, Rhodes and Shire, and a member of the DSMB for Sunovion.
..... Copyright © 1999 - 2016 John Wiley & Sons, Inc. All Rights Reserved.
Oct 6, 2014 ... <sup>3</sup>Shire Development LLC, Wayne, Pennsylvania. ... of the time of GXR
administration (p<0.001 vs. placebo for GXR a.m. and GXR p.m.). ..... Diagnostics,
Enzymotec, GencoSciences, Neos Therapeutics, Shire, and Sunovion.